Different characteristics of cortical spreading depression in the sleep and wake states.
cerebral blood flow
circadian rhythm
cortical spreading depression
optical intrinsic signal
Journal
Headache
ISSN: 1526-4610
Titre abrégé: Headache
Pays: United States
ID NLM: 2985091R
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
revised:
08
03
2022
received:
14
10
2021
accepted:
21
03
2022
pubmed:
26
4
2022
medline:
25
5
2022
entrez:
25
4
2022
Statut:
ppublish
Résumé
The objective of this study is to characterize the effects of the sleep-wake cycle on neurovascular and behavioral characteristics of cortical spreading depression (CSD). There is an important bi-directional relationship between migraine and the sleep-wake cycle, but the basic mechanisms of this relationship are poorly understood. We have developed a minimally invasive microchip system to continuously monitor cerebral blood volume (CBV) with optical intrinsic signal (OIS), head movement, and multiple other physiological and behavioral parameters in freely behaving mice over weeks. Behavior is also monitored with simultaneous video recording. This system can also be used to intermittently trigger and record CSD and accompanying neurovascular and behavioral responses. CSD was triggered optically in different stages of the sleep-wake cycle. The optical stimulus threshold to trigger CSD was significantly higher in the wake state compared to sleep (stimulation duration = 16.4 ± 9.7 s vs. 10.8 ± 5.8 s, p = 0.037, n = 6 mice). CSD evoked in the wake versus sleep state produced changes in CBV that were smaller (largest relative change -4.5 ± 5.0% ∆OIS vs. -14.3 ± 8.5% ∆OIS, p = 0.001) and shorter in duration (33:22 ± 6:37 vs. 49:42 ± 8:05 min:s, p = 0.012, n = 6 mice). The threshold for CSD and kinetics of associated CBV changes were correlated with the time since falling asleep or awakening (n = 47 CSDs in 6 mice). CSD triggered in the wake state was associated with a transient freezing behavior. CSD triggered during sleep typically caused a transient awakening and behavioral response. This was followed by a return to sleep until recovery from the sustained phase of decreased CBV that occurred 30-60 min later, at which time there was consistent awakening with behaviors similar to those that occurred at CSD onset. CSD triggered in the wake state evoked a transient decrease in heart rate (from 11.9 ± 0.8 to 9.6 ± 0.8 Hz, p = 0.002, n = 5), whereas when triggered in the sleep state there was a transient increase in HR (from 7.5 ± 0.4 Hz to 9.3 ± 1.1 Hz, p = 0.016, n = 5). The sleep-wake cycle has significant effects on CSD that may have relevance to the clinical presentations of migraine and brain injury.
Sections du résumé
OBJECTIVE
The objective of this study is to characterize the effects of the sleep-wake cycle on neurovascular and behavioral characteristics of cortical spreading depression (CSD).
BACKGROUND
There is an important bi-directional relationship between migraine and the sleep-wake cycle, but the basic mechanisms of this relationship are poorly understood.
METHODS
We have developed a minimally invasive microchip system to continuously monitor cerebral blood volume (CBV) with optical intrinsic signal (OIS), head movement, and multiple other physiological and behavioral parameters in freely behaving mice over weeks. Behavior is also monitored with simultaneous video recording. This system can also be used to intermittently trigger and record CSD and accompanying neurovascular and behavioral responses. CSD was triggered optically in different stages of the sleep-wake cycle.
RESULTS
The optical stimulus threshold to trigger CSD was significantly higher in the wake state compared to sleep (stimulation duration = 16.4 ± 9.7 s vs. 10.8 ± 5.8 s, p = 0.037, n = 6 mice). CSD evoked in the wake versus sleep state produced changes in CBV that were smaller (largest relative change -4.5 ± 5.0% ∆OIS vs. -14.3 ± 8.5% ∆OIS, p = 0.001) and shorter in duration (33:22 ± 6:37 vs. 49:42 ± 8:05 min:s, p = 0.012, n = 6 mice). The threshold for CSD and kinetics of associated CBV changes were correlated with the time since falling asleep or awakening (n = 47 CSDs in 6 mice). CSD triggered in the wake state was associated with a transient freezing behavior. CSD triggered during sleep typically caused a transient awakening and behavioral response. This was followed by a return to sleep until recovery from the sustained phase of decreased CBV that occurred 30-60 min later, at which time there was consistent awakening with behaviors similar to those that occurred at CSD onset. CSD triggered in the wake state evoked a transient decrease in heart rate (from 11.9 ± 0.8 to 9.6 ± 0.8 Hz, p = 0.002, n = 5), whereas when triggered in the sleep state there was a transient increase in HR (from 7.5 ± 0.4 Hz to 9.3 ± 1.1 Hz, p = 0.016, n = 5).
CONCLUSIONS
The sleep-wake cycle has significant effects on CSD that may have relevance to the clinical presentations of migraine and brain injury.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
577-587Informations de copyright
© 2022 American Headache Society.
Références
Gori S, Lucchesi C, Baldacci F, Bonuccelli U. Preferential occurrence of attacks during night sleep and/or upon awakening negatively affects migraine clinical presentation. Funct Neurol. 2015;30:119-123.
Vgontzas A, Li W, Mostofsky E, Mittleman MA, Bertisch SM. Baseline sleep quality, stress, and depressive symptoms, and subsequent headache occurrence in a six-week prospective cohort study of patients with episodic migraine. Headache. 2021;61:727-733.
Holland PR. Headache and sleep: shared pathophysiological mechanisms. Cephalalgia. 2014;34:725-744.
Charles A. Migraine: a brain state. Curr Opin Neurol. 2013;26:235-239.
Leao AAP, Morison RS. Propagation of spreading cortical depression. J Neurophysiol. 1945;8:33-45.
Charles AC, Baca SM. Cortical spreading depression and migraine. Nat Rev Neurol. 2013;9:637-644.
Hartings JA, Shuttleworth CW, Kirov SA, et al. The continuum of spreading depolarizations in acute cortical lesion development: examining Leao's legacy. J Cereb Blood Flow Metab. 2017;37:1571-1594.
Houben T, Loonen ICM, Baca SM, et al. Optogenetic induction of cortical spreading depression in anesthetized and freely behaving mice. J Cereb Blood Flow Metab. 2017;37:1641-1655.
Harriott AM, Chung DY, Uner A, et al. Optogenetic spreading depression elicits trigeminal pain and anxiety behavior. Ann Neurol. 2021;89:99-110.
Prakash N, Uhlemann F, Sheth SA, Bookheimer S, Martin N, Toga AW. Current trends in intraoperative optical imaging for functional brain mapping and delineation of lesions of language cortex. NeuroImage. 2009;47(Suppl 2):T116-T126.
Chang JC, Shook LL, Biag J, et al. Biphasic direct current shift, haemoglobin desaturation and neurovascular uncoupling in cortical spreading depression. Brain. 2010;133:996-1012.
Brennan KC, Romero-Reyes M, López Valdés HE, Arnold AP, Charles AC. Reduced threshold for cortical spreading depression in female mice. Ann Neurol. 2007;61:603-606.
Brennan KC, Beltran-Parrazal L, Lopez-Valdes HE, Theriot J, Toga AW, Charles AC. Distinct vascular conduction with cortical spreading depression. J Neurophysiol. 2007;97:4143-4151.
Yousef Yengej DN, Ferando I, Kechechyan G, et al. Continuous long-term recording and triggering of brain neurovascular activity and behaviour in freely moving rodents. J Physiol. 2021;599:4545-4559.
Masvidal-Codina E, Smith TM, Rathore D, et al. Characterization of optogenetically-induced cortical spreading depression in awake mice using graphene micro-transistor arrays. J Neural Eng. 2021;18:055002.
Takizawa T, Qin T, Lopes de Morais A, et al. Non-invasively triggered spreading depolarizations induce a rapid pro-inflammatory response in cerebral cortex. J Cereb Blood Flow Metab. 2020;40:1117-1131.
Harriott AM, Chung DY, Uner A, et al. Optogenetic spreading depression elicits trigeminal pain and anxiety behavior. Ann Neurol. 2021;89:99-110.
Ayata C, Jin H, Kudo C, Dalkara T, Moskowitz MA. Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol. 2006;59:652-661.
Pradhan AA, Smith ML, Zyuzin J, Charles A. delta-Opioid receptor agonists inhibit migraine-related hyperalgesia, aversive state and cortical spreading depression in mice. Br J Pharmacol. 2014;171:2375-2384.
Hansen JM, Schankin CJ. Cerebral hemodynamics in the different phases of migraine and cluster headache. J Cereb Blood Flow Metab. 2019;39:595-609.
Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol. 1981;9:344-352.
Cadiot D, Longuet R, Bruneau B, et al. Magnetic resonance imaging in children presenting migraine with aura: association of hypoperfusion detected by arterial spin labelling and vasospasm on MR angiography findings. Cephalalgia. 2018;38:949-958.
Iizuka T, Tominaga N, Kaneko J, et al. Biphasic neurovascular changes in prolonged migraine aura in familial hemiplegic migraine type 2. J Neurol Neurosurg Psychiatry. 2015;86:344-353.
Hansen JM, Schytz HW, Larsen VA, Iversen HK, Ashina M. Hemiplegic migraine aura begins with cerebral hypoperfusion: imaging in the acute phase. Headache. 2011;51:1289-1296.
Denuelle M, Fabre N, Payoux P, Chollet F, Geraud G. Posterior cerebral hypoperfusion in migraine without aura. Cephalalgia. 2008;28:856-862.
Hadjikhani N, Sanchez del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A. 2001;98:4687-4692.
Woods RP, Iacoboni M, Mazziotta JC. Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med. 1994;331:1689-1692.
Jain SV, Kothare SV. Sleep and epilepsy. Semin Pediatr Neurol. 2015;22:86-92.
Petit JM, Eren-Kocak E, Karatas H, Magistretti P, Dalkara T. Brain glycogen metabolism: a possible link between sleep disturbances, headache and depression. Sleep Med Rev. 2021;59:101449.
Chever O, Zerimech S, Scalmani P, et al. Initiation of migraine-related cortical spreading depolarization by hyperactivity of GABAergic neurons and NaV1.1 channels. J Clin Invest. 2021;131:e142203.
Akcali D, Sayin A, Sara Y, Bolay H. Does single cortical spreading depression elicit pain behaviour in freely moving rats? Cephalalgia. 2010;30:1195-1206.
Tepe N, Filiz A, Dilekoz E, et al. The thalamic reticular nucleus is activated by cortical spreading depression in freely moving rats: prevention by acute valproate administration. Eur J Neurosci. 2015;41:120-128.
Filiz A, Tepe N, Eftekhari S, et al. CGRP receptor antagonist MK-8825 attenuates cortical spreading depression induced pain behavior. Cephalalgia. 2019;39:354-365.
Tang C, Unekawa M, Kitagawa S, et al. Cortical spreading depolarisation-induced facial hyperalgesia, photophobia and hypomotility are ameliorated by sumatriptan and olcegepant. Sci Rep. 2020;10:11408.
Zhang X, Levy D, Noseda R, Kainz V, Jakubowski M, Burstein R. Activation of meningeal nociceptors by cortical spreading depression: implications for migraine with aura. J Neurosci. 2010;30:8807-8814.
Tapper AR, Molas S. Midbrain circuits of novelty processing. Neurobiol Learn Mem. 2020;176:107323.
Schmidt EA, Despas F, Pavy-Le Traon A, et al. Intracranial pressure is a determinant of sympathetic activity. Front Physiol. 2018;9:11.
Brennan KC, Charles A. Sleep and headache. Semin Neurol. 2009;29:406-418.
Tiseo C, Vacca A, Felbush A, et al. Migraine and sleep disorders: a systematic review. J Headache Pain. 2020;21:126.
Fox AW, Davis RL. Migraine chronobiology. Headache. 1998;38:436-441.
Kelman L, Rains JC. Headache and sleep: examination of sleep patterns and complaints in a large clinical sample of migraineurs. Headache. 2005;45:904-910.
Gori S, Morelli N, Maestri M, Fabbrini M, Bonanni E, Murri L. Sleep quality, chronotypes and preferential timing of attacks in migraine without aura. J Headache Pain. 2005;6:258-260.
Brennan KC, Bates EA, Shapiro RE, et al. Casein kinase idelta mutations in familial migraine and advanced sleep phase. Sci Transl Med. 2013;5:183ra156.
Daghlas I, Vgontzas A, Guo Y, Chasman DI; International Headache Genetics Consortium; Saxena RI. Habitual sleep disturbances and migraine: a Mendelian randomization study. Ann Clin Transl Neurol. 2020;7:2370-2380.
Hartings JA, Bullock MR, Okonkwo DO, et al. Spreading depolarisations and outcome after traumatic brain injury: a prospective observational study. Lancet Neurol. 2011;10:1058-1064.
Borkum JM. Brain energy deficit as a source of oxidative stress in migraine: a molecular basis for migraine susceptibility. Neurochem Res. 2021;46:1913-1932.